CoChat

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

Open access
Fineberg, Naomi A., Sivakumaran, Thanusha, Roberts, Anne, Gale, Tim · 2005 · International Clinical Psychopharmacology

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

This study aimed to determine the efficacy and tolerability of adding quetiapine to a serotonin reuptake inhibitor in treatment-resistant obsessive-compulsive disorder (OCD). Twenty-one adult treatment-resistant OCD patients were randomized to 16 weeks of augmentation with either quetiapine (n = 11) or placebo (n = 10). Patients with significant comorbidities, including tic-spectrum disorders, were not included. The treatment was well tolerated, with only one premature dropout in each treatment-group. The primary analysis showed that individuals in the quetiapine-treated group showed a 14% mean improvement in baseline Yale-Brown Obsessive-Compulsive Scale scores at study endpoint compared with a 6% improvement in those treated with placebo, but this difference did not reach statistical significance (F<1). Three patients treated with quetiapine met criteria for clinical response, compared to one patient who was treated with placebo. Larger studies are needed to explore the efficacy of second generation antipsychotics, such as quetiapine, when used as adjunct treatment in resistant OCD.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004850-200507000-00005

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 7

  1. Barnes, 1989, Br J Psychiatry, 154, 72???676
  2. Denys, 2004, J Clin Psychiatry, 65, 1040???1048
  3. Goodman, 1989, Arch Gen Psychiatry, 46, 1006???1011
  4. Leon, 1992, Soc Psychiatry Psychiatr Epidemiol, 27, 78???82
  5. March, 1997, J Clin Psychiatry, 58, 1???72
  6. McDougle, 1994, Arch Gen Psychiatry, 51, 302???308
  7. Simpson, 1970, Acta Psychiatr Scand Suppl, 212, S11???S19

Cited by

See all 114

Metadata

Authors
Fineberg, N. A., Sivakumaran, T., Roberts, A., & Gale, T.
Affiliations
  • Queen Elizabeth II Hospital (GB)
  • University of Hertfordshire (GB)
Corresponding author
Fineberg, Naomi A.
Venue
International Clinical Psychopharmacology
Published
2005-07
Volume
20
Issue
4
Pages
223-226
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2069929468
Cited by
105
References
15
Citations by year
2026: 1 · 2024: 4 · 2023: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 5 · 2012: 8
FWCI
12.34
Type
journal article
Language
en
Licence
cc-by-nc-nd
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion, cc-by-nc-nd)
Funders
AstraZeneca
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
quetiapine, treatment-resistant OCD, serotonin reuptake inhibitors, augmentation therapy, atypical antipsychotics, Yale-Brown Obsessive Compulsive Scale, tolerability, adjunctive therapy
MeSH terms
Quetiapine Fumarate, Adult, Dibenzothiazepines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Placebos, Antipsychotic Agents, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. https://app.cochat.ai/papers/10.1097/00004850-200507000-00005
The paper
Fineberg, N. A., Sivakumaran, T., Roberts, A., & Gale, T. (2005). Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200507000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.